Cerus Corporation to Participate in Upcoming Investor Conferences
February 01 2024 - 8:30AM
Business Wire
Cerus Corporation (Nasdaq: CERS) announced management
participation in two upcoming investor conferences.
Management plans to attend the BTIG 11th Annual MedTech, Digital
Health, Life Science & Diagnostic Tools Conference on Tuesday,
February 13th and will participate in TD Cowen’s 44th Annual Health
Care Conference on Wednesday, March 6th at 11:10 AM EST.
A live webcast of the TD Cowen presentation will be available
here and the replay will be available on the Company’s website
after the event.
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the
world’s blood supply and aims to become the preeminent global blood
products company. Headquartered in Concord, California, the company
develops and supplies vital technologies and pathogen-protected
blood components to blood centers, hospitals, and ultimately
patients who rely on safe blood. The INTERCEPT Blood System for
platelets and plasma is available globally and remains the only
pathogen reduction system with both CE mark and FDA approval for
these two blood components. The INTERCEPT red blood cell system is
under regulatory review in Europe, and in late-stage clinical
development in the U.S. Also in the U.S., the INTERCEPT Blood
System for Cryoprecipitation is approved for the production of
Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly
referred to as INTERCEPT Fibrinogen Complex), a therapeutic product
for the treatment and control of bleeding, including massive
hemorrhage, associated with fibrinogen deficiency. For more
information about Cerus, visit www.cerus.com and follow us on
LinkedIn.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus
Corporation.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240201398941/en/
Jessica Hanover – Vice President, Corporate Affairs Cerus
Corporation 925-288-6137
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cerus (NASDAQ:CERS)
Historical Stock Chart
From Apr 2023 to Apr 2024